LANDONI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 23.973
AS - Asia 13.055
EU - Europa 9.657
SA - Sud America 2.124
Continente sconosciuto - Info sul continente non disponibili 1.102
AF - Africa 308
OC - Oceania 36
Totale 50.255
Nazione #
US - Stati Uniti d'America 22.290
SG - Singapore 5.019
IT - Italia 3.162
CN - Cina 2.257
HK - Hong Kong 2.101
RU - Federazione Russa 1.676
BR - Brasile 1.601
VN - Vietnam 1.537
CA - Canada 1.387
SE - Svezia 976
IE - Irlanda 933
DE - Germania 891
BD - Bangladesh 504
FR - Francia 411
GB - Regno Unito 385
UA - Ucraina 384
IN - India 383
FI - Finlandia 202
AR - Argentina 188
ID - Indonesia 169
KR - Corea 153
IQ - Iraq 142
TR - Turchia 135
MX - Messico 131
ZA - Sudafrica 114
NL - Olanda 109
ES - Italia 100
AT - Austria 98
JP - Giappone 94
CO - Colombia 88
PK - Pakistan 81
SA - Arabia Saudita 75
PH - Filippine 70
VE - Venezuela 64
EC - Ecuador 62
PL - Polonia 53
UZ - Uzbekistan 44
CH - Svizzera 42
DK - Danimarca 42
CR - Costa Rica 38
MA - Marocco 37
CL - Cile 36
PY - Paraguay 35
MY - Malesia 32
AE - Emirati Arabi Uniti 31
JM - Giamaica 31
EG - Egitto 30
AU - Australia 28
BE - Belgio 26
TN - Tunisia 26
KE - Kenya 25
SK - Slovacchia (Repubblica Slovacca) 23
PE - Perù 22
RO - Romania 21
HN - Honduras 19
IL - Israele 19
JO - Giordania 19
AZ - Azerbaigian 17
IR - Iran 17
TH - Thailandia 17
UY - Uruguay 17
PS - Palestinian Territory 16
CZ - Repubblica Ceca 15
KZ - Kazakistan 15
LT - Lituania 15
NP - Nepal 15
OM - Oman 15
DZ - Algeria 14
ET - Etiopia 14
LB - Libano 13
NG - Nigeria 13
TT - Trinidad e Tobago 13
AL - Albania 12
NI - Nicaragua 12
RS - Serbia 12
BO - Bolivia 11
TW - Taiwan 11
BG - Bulgaria 10
EE - Estonia 10
PT - Portogallo 10
KG - Kirghizistan 9
PA - Panama 9
DO - Repubblica Dominicana 8
EU - Europa 8
HR - Croazia 7
KW - Kuwait 7
MN - Mongolia 7
SV - El Salvador 7
AO - Angola 6
BB - Barbados 6
MD - Moldavia 6
SN - Senegal 6
BY - Bielorussia 5
GE - Georgia 5
GT - Guatemala 5
HU - Ungheria 5
NZ - Nuova Zelanda 5
BH - Bahrain 4
GR - Grecia 4
LA - Repubblica Popolare Democratica del Laos 4
Totale 49.088
Città #
Singapore 2.959
Ashburn 2.374
Ann Arbor 2.072
Hong Kong 2.060
San Jose 1.434
Fairfield 1.398
Toronto 1.163
Milan 988
Woodbridge 965
Dublin 894
Houston 801
Wilmington 693
New York 654
Santa Clara 651
Chandler 637
Seattle 526
Cambridge 502
Chicago 470
Frankfurt am Main 465
Princeton 446
Council Bluffs 432
Ho Chi Minh City 401
Beijing 362
Los Angeles 343
The Dalles 321
Rome 319
Hanoi 315
Jacksonville 302
Dallas 279
Dearborn 278
Hefei 267
Lauterbourg 236
Lawrence 197
Boardman 186
Altamura 167
São Paulo 150
Moscow 145
Seoul 144
Buffalo 143
Helsinki 126
San Diego 126
Nanjing 106
Shanghai 105
Phoenix 101
Jakarta 97
London 97
Dong Ket 89
Guangzhou 85
Andover 82
Atlanta 80
Hamburg 76
Munich 74
Columbus 69
Tokyo 68
Fremont 61
Nuremberg 61
Orem 61
Brooklyn 60
Haiphong 60
Vienna 60
Denver 59
Rio de Janeiro 58
Baghdad 57
Montreal 57
Salt Lake City 54
Figino 53
Turin 52
Chennai 51
Da Nang 50
Mumbai 50
Naples 48
San Francisco 45
Johannesburg 44
Dhaka 43
Bologna 42
Boston 42
Lachine 41
Curitiba 40
Tashkent 40
Tianjin 38
Miami 37
Washington 37
Warsaw 34
Biên Hòa 33
Norwalk 33
Philadelphia 33
Brasília 32
Nanchang 31
Lissone 30
Falls Church 29
Florence 29
Tampa 29
Pune 28
Shenyang 28
Amsterdam 27
Riyadh 27
Stockholm 27
Bogotá 25
Mexico City 25
Monza 25
Totale 30.446
Nome #
High-dose epirubicin in patients with advanced or recurrent uterine sarcoma 593
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 560
Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3 493
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 470
Ovarian function, fertility, and menopause occurrence after fertility-sparing surgery and chemotherapy for ovarian neoplasms 455
An Overview of PARP Resistance in Ovarian Cancer from a Molecular and Clinical Perspective 437
Genomic and epigenomic profile of uterine smooth muscle tumors of uncertain malignant potential (Stumps) revealed similarities and differences with leiomyomas and leiomyosarcomas 437
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 423
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis 406
Erratum: Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Annals of Oncology (2017) 28 (iv72-iv83) DOI: 10.1093/annonc/mdx220) 405
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers 386
Clinical outcome of patients with malignant tumors associated with mature cystic teratomas of the ovary: A retrospective multicenter Italian study 384
Standard ultra-staging compared to one-step nucleic acid amplification for the detection of sentinel lymph node metastasis in endometrial cancer patients: a retrospective cohort comparison 380
Two ultrastaging protocols for the detection of lymph node metastases in early-stage cervical and endometrial cancers 369
The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis 348
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer 341
The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study 336
European Society of Gynaecological Oncology quality indicators for surgical treatment of cervical cancer 332
Lymph node evaluation in high-risk early stage endometrial cancer: A multi-institutional retrospective analysis comparing the sentinel lymph node (SLN) algorithm and SLN with selective lymphadenectomy 318
Imact of bevacizumab-containing primary treatment on outcome of recurrent ovarian cancer: An Italian study 317
Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy 311
Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: A prospective randomized study 305
Low-Volume Metastases in Cervical Cancer: Does Size Matter? 304
Prevalence of Chlamydia trachomatis Infection, Serovar Distribution and Co-Infections with Seven High-Risk HPV Types among Italian Women with a Recent History of Abnormal Cervical Cytology 294
Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study 290
Dose-dense neoadjuvant chemotherapy with paclitaxel and carboplatin in cervical cancer: Efficacy on pathological response 285
Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy 283
Fertility outcomes in stage I ovarian immature teratomas 283
The role of pelvic and aortic lymphadenectomy at second look surgery in apparent early stage ovarian cancer after inadequate surgical staging followed by adjuvant chemotherapy 283
Association between physical activity and menstrual cycle disorders in young athletes 281
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 281
The clinical significance of the tumor marker CA-125 281
Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy 278
Uterine leiomyosarcoma: analysis of treatment failures and survival 277
Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial 277
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk 276
Molecular Detection of Human Papillomavirus (HPV) and Other Sexually Transmitted Pathogens in Cervical and Self-Collected Specimens 270
Onclarity Human Papillomavirus Extended Genotyping in the Management of Cervical Intraepithelial Neoplasia 2+ Lesions 268
Neoadjuvant platinum-based chemotherapy followed by radical hysterectomy for stage Ib2-IIb adenocarcinoma of the uterine cervix – An Italian multicenter retrospective study 268
Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma 264
Oncologic and obstetric outcomes after simple conization for fertility-sparing surgery in FIGO 2018 stage IB1 cervical cancer 259
Borderline ovarian cancer 259
Evaluation of two alternative non-alcohol-based media for the suspension of self-collected vaginal swabs for HPV testing in cervical cancer screening 258
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study 256
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma 250
Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience 248
Copy number alterations in stage I epithelial ovarian cancer highlight three genomic patterns associated with prognosis 247
Cancer in pregnancy: Proposal of an italian multicenter study. gynecologic oncology group of the italian society of gynecology and obstetrics (sigo) 243
Endometrial stromal sarcoma: analysis of treatment failures and survival 241
Diffusion-weighted MR imaging in assessing cervical tumour response to nonsurgical therapy 240
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer 239
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study 238
Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study 237
Anatomical Spaces in Radical Hysterectomy for Cervical Cancer 236
Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: Single institution experience 233
Brachytherapy for isolated vaginal recurrences from endometrial carcinoma 232
Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer 232
Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB 232
Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 231
Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients 231
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study 231
Early oral versus "traditional" postoperative feeding in gynecologic oncology patients undergoing intestinal resection: A randomized controlled trial 230
Robotic Surgery: Changing the Surgical Approach for Endometrial Cancer in a Referral Cancer Center 229
Risk-reducing salpingo-oophorectomy in women at higher risk of ovarian and breast cancer: A single institution prospective series 227
Chemo-conization in early cervical cancer 226
The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN study 225
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic 225
Randomized study between radical surgery and radiotherapy for the treatment of stage IB–IIA cervical cancer: 20-year update 223
European society of gynaecological oncology guidelines for the management of patients with Vulvar cancer 223
Clinical correlates of in vitro drug sensitivities of ovarian cancer cells 223
Oncologic and fertility outcomes in patients with juvenile granulosa cell tumor - a retrospective single centre analysis 221
The clinical implementation of primary HPV screening 221
Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture 221
Radical Hysterectomy in Early-Stage Cervical Cancer: Abandoning the One-Fits-All Concept 220
Reduction of postoperative complication rate with the use of early oral feeding in gynecologic oncologic patients undergoing a Major surgery: A randomized controlled trial 220
Low-Volume Metastases in Apparent Early-Stage Endometrial Cancer: Prevalence, Clinical Significance, and Future Perspectives 219
Endometriosis-related spontaneous hemoperitoneum in pregnancy: A case series 216
Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary 216
Fertility-Sparing Options in Young Women with Cervical Cancer 215
Intense neoadjuvant chemotherapy with cisplatin and epirubicin for advanced or bulky cervical and vaginal adenocarcinoma 214
Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis 213
Pre-chemotherapy hemoglobin levels and survival in patients with advanced epithelial ovarian cancer who received a first-line taxane/platinum-based regimen: Results of a multicenter retrospective Italian study 213
DNA index of ovarian carcinomas from 56 patients: In vivo in vitro studies 211
Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study 210
Eviscerazione pelvica 210
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 209
Could different follow-up modalities play a role in the diagnosis of asymptomatic endometrial cancer relapses?: An Italian multicentric retrospective analysis 208
Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers 207
Chlamydia trachomatis infection and HPV/Chlamydia trachomatis co-infection among HPV-vaccinated young women at the beginning of their sexual activity 207
Colposcopy Accuracy and Diagnostic Performance: A Quality Control and Quality Assurance Survey in Italian Tertiary-Level Teaching and Academic Institutions—The Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV) 206
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 206
Adult primary cervical rhabdomyosarcomas: A Multicentric cross-national case series 206
Genomic instability analysis in DNA from Papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer 203
Accuracy of sexually transmitted infections testing on self-collected vaginal samples versus cervical samples 201
Postoperative Complications After Cytoreductive Surgery for Advanced Ovarian Carcinoma: A Single-Center Analysis Exploring the Value of the Comprehensive Complication Index and the Predictors of High Complications Burden 200
Teniposide in refractory ovarian cancer: a phase II study 200
Prevalence and Risk Factors of Human Papillomavirus Infection in 18-Year-Old Women: Baseline Report of a Prospective Study on Human Papillomavirus Vaccine 200
Robotic approach for cervical cancer: comparison with laparotomy: a case control study 199
Effectiveness of autologous blood transfusion in patients undergoing radical hysterectomy 199
Gestational Intraplacental Choriocarcinoma in a Term Pregnancy: A Case Report 196
Totale 27.240
Categoria #
all - tutte 177.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 177.826


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.809 0 0 0 170 160 164 127 169 129 199 212 479
2022/20233.348 477 912 250 221 228 561 58 172 254 32 90 93
2023/20242.974 73 63 180 123 432 688 553 67 310 68 52 365
2024/20258.222 408 1.160 600 381 662 332 405 242 920 1.216 612 1.284
2025/202619.077 1.627 1.174 1.338 1.934 1.967 971 2.605 1.081 1.474 1.326 1.659 1.921
2026/20274.383 893 1.051 2.186 253 0 0 0 0 0 0 0 0
Totale 50.255